Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients

Chronic Pain Clinical Trial

Official title:

Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients: A Prospective Analysis of Immunoassay and Liquid Chromatography Tandem Mass Spectometry (LC/MS/MS)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01052155
• Other study ID #: Protocol 26
• Status: Completed
• Phase: N/A
• First received: January 18, 2010
• Last updated: March 11, 2011
• Start date: February 2010
• Est. completion date: June 2010

Study information

• Verified date: March 2011
• Source: Pain Management Center of Paducah
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients: A Prospective Analysis of Immunoassay and Liquid Chromatography Tandem Mass Spectometry (LC/MS/MS)

Description:

Recruitment is indicated in patients with chronic pain management with or without controlled substance therapy.

This is a diagnostic accuracy study performed in an interventional pain management referral center in the United States.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1000
• Est. completion date: June 2010
• Est. primary completion date: June 2010
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria:

• Chronic pain management with or without controlled substance therapy.

Exclusion criteria:

Related Conditions & MeSH terms

• Chronic Pain

Intervention

Other:
• Urine Drug Testing
LC/MS/MS Laboratory Evaluation

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Pain Management Center of Paducah	Millennium Laboratories

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Diagnostic accuracy		72 hours